(Q51324154)

3 April 2018

title

Fibroblast growth factor 21 and its relation to metabolic parameters in women with polycystic ovary syndrome. (English)

1 reference

3 April 2018

polycystic ovary syndrome

main subject

1 reference

1 reference

Serap B Sahin

1

1 reference

3 April 2018

Teslime Ayaz

2

1 reference

3 April 2018

Medine C Cure

3

1 reference

3 April 2018

Hacer Sezgin

4

1 reference

3 April 2018

Ulku M Ural

5

1 reference

3 April 2018

Gulsah Balik

6

1 reference

3 April 2018

Figen K Sahin

7

1 reference

3 April 2018

publication date

11 April 2014

1 reference

3 April 2018

Scandinavian Journal of Clinical and Laboratory Investigation

published in

1 reference

3 April 2018

volume

74

1 reference

3 April 2018

issue

6

1 reference

3 April 2018

page(s)

465-469

1 reference

3 April 2018

The prevalence and features of the polycystic ovary syndrome in an unselected population

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

Long-term health consequences of PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

Polycystic ovary syndrome and cardiovascular disease: a premature association?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

The role of fibroblast growth factor 21 (FGF21) on energy balance, glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

FGF-21 as a novel metabolic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

Liver fat but not other adiposity measures influence circulating FGF21 levels in healthy young adult twins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

Relationship of serum fibroblast growth factor 21 with abnormal glucose metabolism and insulin resistance: the Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

Clinical assessment of body hair growth in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

High Prevalence of Diabetes in Adana, a Southern Province of Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

Serum fibroblast growth factor 21 levels in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.900821

10.3109/00365513.2014.900821

21 January 2018

Identifiers

DOI

1 reference

3 April 2018

1 reference

3 April 2018